enGene Therapeutics Inc.

Leadership moves, last update 1 month ago

Pharma biotech · Headquarters Canada

Everything we hold on enGene Therapeutics Inc., newest first. Every line links to the filing or report it came from.

This profile is thin because we hold 2 source documents on enGene Therapeutics Inc. so far, not because nothing else has happened there. We only publish what we have read on a primary source and can link to. So a profile fills up as filings and reports come in, and we never seed it from an estimate. We keep profiles at this stage out of our sitemap and mark them noindex until they carry enough to be worth a search result of their own.

1. 2026-07-16
   Headcount Not Stated Leadership moves

   enGene Therapeutics Inc. Announces Resignation of Director and Chairman

   Dr. Richard Glickman steps down from his roles at enGene Therapeutics in Saint-Laurent, Quebec. The announcement does not disclose plans for his replacement.

   Canada · Official Filing · SEC EDGAR

2. 2026-05-07
   Headcount Not Stated Leadership moves

   enGene Therapeutics Inc. 8-K filing: officer or director change

   Dr. Hussein Sweiti's employment terms were updated at enGene Therapeutics, effective May 6, 2026. The announcement does not disclose hiring plans.

   United States · Official Filing · SEC EDGAR

The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker